Literature DB >> 19188603

Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1.

Carol W M Chan1, Newton A Wong, Ying Liu, David Bicknell, Helen Turley, Laura Hollins, Crispin J Miller, Jennifer L Wilding, Walter F Bodmer.   

Abstract

CDX1 is a transcription factor that plays a key role in intestinal development and differentiation. However, the downstream targets of CDX1 are less well defined than those of its close homologue, CDX2. We report here the identification of downstream targets of CDX1 using microarray gene-expression analysis and other approaches. Keratin 20 (KRT20), a member of the intermediate filament and a well-known marker of intestinal differentiation, was initially identified as one of the genes likely to be directly regulated by CDX1. CDX1 and KRT20 mRNA expression were significantly correlated in a panel of 38 colorectal cancer cell lines. Deletion and mutation analysis of the KRT20 promoter showed that the minimum regulatory region for the control of KRT20 expression by CDX1 is within 246 bp upstream of the KRT20 transcription start site. ChIP analysis confirmed that CDX1 binds to the predicted CDX elements in this region of the KRT20 promoter in vivo. In addition, immunohistochemistry showed expression of CDX1 parallels that of KRT20 in the normal crypt, which further supports their close relationship. In summary, our observations strongly imply that KRT20 is directly regulated by CDX1, and therefore suggest a role for CDX1 in maintaining differentiation in intestinal epithelial cells. Because a key feature of the development of a cancer is an unbalanced program of proliferation and differentiation, dysregulation of CDX1 may be an advantage for the development of a colorectal carcinoma. This could, therefore, explain the relatively frequent down regulation of CDX1 in colorectal carcinomas by hypermethylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188603      PMCID: PMC2644142          DOI: 10.1073/pnas.0812904106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Keratins: guardians of the liver.

Authors:  M Bishr Omary; Nam-On Ku; Diana M Toivola
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  Analysis of the regulation of the A33 antigen gene reveals intestine-specific mechanisms of gene expression.

Authors:  Cameron N Johnstone; Sara J White; Niall C Tebbutt; Fiona J Clay; Matthias Ernst; William H Biggs; Carrie S Viars; Suzanne Czekay; Karen C Arden; Joan K Heath
Journal:  J Biol Chem       Date:  2002-07-11       Impact factor: 5.157

3.  The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis.

Authors:  Mirentxu Santos; Jesus M Paramio; Ana Bravo; Angel Ramirez; José L Jorcano
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

4.  Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer.

Authors:  S Wildi; J Kleeff; H Maruyama; C A Maurer; H Friess; M W Büchler; A D Lander; M Korc
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

5.  Keratin 8 mutations in patients with cryptogenic liver disease.

Authors:  N O Ku; R Gish; T L Wright; M B Omary
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

6.  Expression of the gut-enriched Krüppel-like factor (Krüppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2.

Authors:  D T Dang; C S Mahatan; L H Dang; I A Agboola; V W Yang
Journal:  Oncogene       Date:  2001-08-09       Impact factor: 9.867

7.  Human intestinal epithelial cell-derived interleukin (IL)-18, along with IL-2, IL-7 and IL-15, is a potent synergistic factor for the proliferation of intraepithelial lymphocytes.

Authors:  A Okazawa; T Kanai; K Nakamaru; T Sato; N Inoue; H Ogata; Y Iwao; M Ikeda; T Kawamura; S Makita; K Uraushihara; R Okamoto; M Yamazaki; M Kurimoto; H Ishii; M Watanabe; T Hibi
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

8.  Keratin 20 helps maintain intermediate filament organization in intestinal epithelia.

Authors:  Qin Zhou; Diana M Toivola; Ningguo Feng; Harry B Greenberg; Werner W Franke; M Bishr Omary
Journal:  Mol Biol Cell       Date:  2003-04-04       Impact factor: 4.138

9.  Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines.

Authors:  N A C S Wong; M P Britton; G S Choi; T K Stanton; D C Bicknell; J L Wilding; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

10.  Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines.

Authors:  Patrícia Mesquita; Nicolas Jonckheere; Raquel Almeida; Marie-Paule Ducourouble; Jacinta Serpa; Elisabete Silva; Pascal Pigny; Filipe Santos Silva; Celso Reis; Debra Silberg; Isabelle Van Seuningen; Leonor David
Journal:  J Biol Chem       Date:  2003-10-02       Impact factor: 5.157

View more
  41 in total

1.  Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds.

Authors:  Junqing Ye; Jian Ge; Xu Zhang; Lin Cheng; Zhengyuan Zhang; Shan He; Yuping Wang; Hua Lin; Weifeng Yang; Junfang Liu; Yang Zhao; Hongkui Deng
Journal:  Cell Res       Date:  2015-12-25       Impact factor: 25.617

2.  T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis.

Authors:  Melinda L Angus-Hill; Kathryn M Elbert; Julio Hidalgo; Mario R Capecchi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

3.  Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach.

Authors:  Tilman T Rau; Anja Rogler; Myrjam Frischauf; Andreas Jung; Peter C Konturek; Arno Dimmler; Gerhard Faller; Bettina Sehnert; Wael El-Rifai; Arndt Hartmann; Reinhard E Voll; Regine Schneider-Stock
Journal:  Am J Pathol       Date:  2012-06-27       Impact factor: 4.307

4.  Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells.

Authors:  Trevor M Yeung; Shaan C Gandhi; Walter F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-23       Impact factor: 11.205

5.  Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.

Authors:  Yingjie Yu; Fazlul H Sarkar; Adhip P N Majumdar
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

6.  Colonic 15-PGDH levels are stable across distance and time and are not perturbed by aspirin intervention.

Authors:  Stephen P Fink; Dong-Hoon Yang; Jill S Barnholtz-Sloan; Yeon-Mi Ryu; Debra Mikkola; John D Potter; Johanna W Lampe; Sanford D Markowitz; Seung-Jae Myung
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

Review 7.  Biology of Barrett's esophagus and esophageal adenocarcinoma.

Authors:  David H Wang; Rhonda F Souza
Journal:  Gastrointest Endosc Clin N Am       Date:  2011-01

8.  Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia.

Authors:  David H Wang; Anjana Tiwari; Monica E Kim; Nicholas J Clemons; Nanda L Regmi; William A Hodges; David M Berman; Elizabeth A Montgomery; D Neil Watkins; Xi Zhang; Qiuyang Zhang; Chunfa Jie; Stuart J Spechler; Rhonda F Souza
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

9.  EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis.

Authors:  Y Feng; X Dai; X Li; H Wang; J Liu; J Zhang; Y Du; L Xia
Journal:  Cell Prolif       Date:  2012-10       Impact factor: 6.831

Review 10.  Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.

Authors:  Marc El Beaino; Jason Roszik; John A Livingston; Wei-Lien Wang; Alexander J Lazar; Behrang Amini; Vivek Subbiah; Valerae Lewis; Anthony P Conley
Journal:  Curr Oncol Rep       Date:  2018-03-26       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.